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Problem Identification and Description 
of Need 
 Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United 
States, with approximately 2.7-3.9 million people living with chronic infections. (1)
 Approximately 75%–85% of people who become infected with hepatitis C virus will 
develop a chronic infection. (2) From those infected, up to 75% are unaware of it due to 
the asymptomatic nature of the disease. (3)
 Those born between the years 1945-1965 are at a five-fold increased risk of HCV infection. 
Hepatitis C is a leading cause of cirrhosis, hepatocellular carcinoma, and liver 
transplantations; people born during 1945-1965 account for 73% of all hepatitis C-
associated mortality. (4)
 According to surveillance surveys, an estimated 12,000 people are infected with Hepatitis 
C in Vermont. There are now over 200,000 Vermonters born from 1945 to 1965 who need 
to be screened solely due to the birth cohort. 
 With the advancement of modern medicine, new therapies have emerged that can cure 
chronic HCV infections in a short duration of time with few associated side effects, thus 
increasing the importance of screening for the disease and intervening to halt its progress. 
Public health cost 
 In 2013 the total cost of Hepatitis C burden in the U.S. was estimated at 
$6.5 ($4.3-$8.4) billion and it is expected to peak in 2024 at $9.1 ($6.4-$13.3) 
billion (5)
 The lifetime cost of an individual infected with HCV in 2011 was estimated 
at $64,490 (5)
 One-time testing of the baby boomer cohort is estimated to identify 
800,000 infections and, with linkage to care and treatment, avert more 
than 120,000 HCV-related deaths. This preventative strategy is estimated 
to save $1.5-$7.1 billion in liver disease-related costs. (4)
Community perspective and support 
 Dr. Max Bayard 
 “Undoubtedly a lot of people are not seeing, or have access to, doctors to get 
screened for Hepatitis C infection”
 “Doctors also need to be educated to remember and address Hepatitis C as part 
of the routine screening in the baby boomer population”
 Dr. Michael Corrigan 
 “A few years ago, we were amazed at how many of our patients with a history of 
high risk behavior tested positive for Hepatitis C- Antibodies and subsequently 
Hepatitis C viral RNA. We then began screening in the baby boomer age group 
with and without a history of high risk behavior. We continued to identify many 
asymptomatic infected people and referred them onto treatment and a cure.”
Intervention and Methodology 
 Project Objective: To raise awareness and educate patients within the 
baby boomer population to get screened for Hepatitis C. 
 Methodology: A literature review was conducted regarding the utility and 
efficacy of Hepatitis C screening and an 8.5x11” poster was created to be 
posted in both Dr. Corrigan and Dr. Bayard’s office waiting rooms. 
 The poster was made to educate and inform patients about the risks and 
previous exposures that could potentially lead to an infection with HCV. 
 The poster aims to start a conversation about preventative medicine between 
the patient and the provider and ultimately it aims to increase the amount of 
patients within the baby boomer cohort to get tested for HCV. 
Results: Poster 
Evaluation of effectiveness and 
limitations
 The poster was reviewed and approved by Dr. Bayard and other 
healthcare providers in the St. Albans NOTCH clinic. The Poster was also 
reviewed by Dr. Corrigan and received a positive response and reaction. 
 The poster was completed and displayed towards the end of the rotation 
thus my ability to gauge its effectiveness is very limited due to time. 
 Hepatitis C infection is also a complex disorder with multiple variables, 
making it difficult to effectively portray an educational message to the 
laymen on such a poster. 
 The actual size of the poster (8.5 x 11”) is also small, which limits the amount 
of attention it could attract from patients, especially the visually impaired.  
Recommendations for future 
interventions/projects
 Follow up in six months to quantify the number of Hepatitis C screening tests 
that have been ordered after the poster was displayed in comparison to six 
months prior to the poster being displayed. 
 Another great way of raising awareness for screening would be to approach it 
from the providers angle and have them bring up the topic to every patient 
that falls withinin this cohort. Due to the small office settings this can be a 
protocol change for all providers practicing in that clinic. 
 Additionally, asking about previous Hep C testing in the new patient 
questionnaires and intake forms would give the providers more information 
about their patient population. 
 Another intervention can be in the form of an automatic reminder from the 
EMR which prompts the provider that this patient has never been tested and to 
inquire about possible screening. 
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